MFS
AVEO

MSI Financial Services’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

MSI Financial Services’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1K Hold
100
– – ﹤0.01% 3759
2016
Q3 		$1K Buy
+100
New +$941 ﹤0.01% 3793

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

MSI Financial Services's AVEO Position: Q4 2016 in Review

MSI Financial Services held its AVEO Pharmaceuticals, Inc. (AVEO) position steady in Q4 2016 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

MSI Financial Services first reported a position in AVEO in Q3 2016 and has held it in 2 quarters since. 44 funds tracked by Wall St. Rank hold AVEO as of Q4 2016.

  • MSI Financial Services held 100 shares of AVEO Pharmaceuticals, Inc. worth $1K as of Q4 2016.
  • MSI Financial Services left its AVEO Pharmaceuticals, Inc. share count unchanged in Q4 2016.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3759 holding.
  • MSI Financial Services first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2016 and has held it in 2 quarters since.
  • 44 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.